Copper homeostasis and cuproptosis in cardiovascular disease therapeutics

Lifang Yang; Pingping Yang; Professor Gregory Lip; Jun Ren

doi:10.1016/j.tips.2023.07.004

Related publications

Letter2022

Cuproptosis: a copper-triggered modality of mitochondrial cell death

Daolin Tang, Xin Chen, Guido Guido Kroemer

Book1994

Therapeutics in Respiratory Disease

Peter J Barnes, Kian W. Evans, Timothy W. Evans

Article2014

Wilson Disease Protein ATP7B Utilizes Lysosomal Exocytosis to Maintain Copper Homeostasis

Elena V. Polishchuk, Mafalda Concilli, Simona Iacobacci, Giancarlo Chesi, Nunzia Pastore, Pasquale Piccolo, Simona Paladino, Daniela Baldantoni, Sven C.D. van IJzendoorn, Jefferson Chan, Christopher J Chang, Angela Amoresano, Francesca Pane, Piero Pucci, Antonietta Tarallo, Giancarlo Parenti, Nicola Brunetti‐Pierri, Carmine Settembre, Andrea Ballabio, Roman Polishchuk

Article2010

Frontiers in Alzheimer’s disease therapeutics

Jeremy Stone, Gemma Casadesús, Kasia Gustaw‐Rothenberg, Sandra L. Siedlak, Xinglong Wang, Xiongwei Zhu, George Perry, Rudy J. Castellani, Mark A. Smith

Article2025

Abstract 4371070: Mechanistic Insight into Disturbed Flow–Induced Mitochondrial Copper Overload and Cuproptosis in Atherosclerosis

Sudhahar Varadarajan, Zhen Xiao, Archita Das, Dipankar Ash, Shikha Yadav, Stephanie Kelley. Spears, Jaekwon Lee, Hanjoong Jo, Christopher J Chang, Jianghong Rao, Jack H. Kaplan, Masuko Ushio‐Fukai, Tohru Fukai